28 related articles for article (PubMed ID: 12493032)
1. Concurrent T-cell/histiocyte-rich large B-cell lymphoma and HHV-6A-infected T-cell proliferation: a diagnostic pitfall.
Bruehl FK; Norgan AP; Shi M; Rech KL; Ding Y; Pittaluga S; Yuan J
Histopathology; 2023 Dec; 83(6):999-1002. PubMed ID: 37661776
[No Abstract] [Full Text] [Related]
2. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
3. 'T-cell-rich large B-cell lymphoma'-'histiocyte-rich, T-cell-rich large B-cell lymphoma'-'T-cell/histiocyte-rich large B-cell lymphoma': will we ever see the wood for the trees?
De Wolf-Peeters C; Achten R
Histopathology; 2002 Sep; 41(3):269-71. PubMed ID: 12207791
[No Abstract] [Full Text] [Related]
4. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
5. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
[TBL] [Abstract][Full Text] [Related]
6. Sequential immunohistochemistry: a promising new tool for the pathology laboratory.
van den Brand M; Hoevenaars BM; Sigmans JH; Meijer JW; van Cleef PH; Groenen PJ; Hebeda KM; van Krieken JH
Histopathology; 2014 Nov; 65(5):651-7. PubMed ID: 24766252
[TBL] [Abstract][Full Text] [Related]
7. Histiocyte and T-cell-rich B-cell lymphoma with Langhans giant cells.
Suárez-Vilela D; Izquierdo-García FM
Histopathology; 2003 Jan; 42(1):92-3. PubMed ID: 12493032
[No Abstract] [Full Text] [Related]
8. B-cell markers in lymphocyte predominance Hodgkin disease.
Torlakovic E; Torlakovic G
Arch Pathol Lab Med; 2002 Jul; 126(7):862-3. PubMed ID: 12123231
[No Abstract] [Full Text] [Related]
9. T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases.
Baddoura FK; Chan WC; Masih AS; Mitchell D; Sun NC; Weisenburger DD
Am J Clin Pathol; 1995 Jan; 103(1):65-75. PubMed ID: 7817948
[TBL] [Abstract][Full Text] [Related]
10. Selected case studies in hematopathology: application of current ancillary techniques in diagnosis.
Reddy VV
Adv Exp Med Biol; 2005; 563():112-24. PubMed ID: 16433127
[No Abstract] [Full Text] [Related]
11. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
[TBL] [Abstract][Full Text] [Related]
12. [Concerning the so-called Lennert's lymphoma].
Rupniewska ZM
Pol Arch Med Wewn; 1982; 68(3):163-6. PubMed ID: 6763210
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
